Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease
标签扩展、单臂、III期研究表明,stempeucel® 对因动脉粥样硬化性外周动脉疾病引起的严重肢体缺血患者有效且安全。
期刊:Stem Cell Research & Therapy
影响因子:7.3
doi:10.1186/s13287-023-03292-w
Gupta, Pawan Kumar; Shivashankar, P; Rajkumar, M; Mahapatra, Subhendu S; Desai, Sanjay C; Dhar, Anita; Krishna, Vinay; Raviraja, N S; Bhat, Samatha; Viswanathan, Pachaiyappan; Kannan, Suresh; Abraham, Jijy; Boggarapu, Hema; Manjuprasad, M S; Udaykumar, K